Sodium butyrate activates HMGCS2 to promote ketone body production through SIRT5-mediated desuccinylation

Abstract

Ketone bodies have beneficial metabolic activities, and the induction of plasma ketone bodies is a health promotion strategy. Dietary supplementation of sodium butyrate (SB) is an effective approach in the induction of plasma ketone bodies. However, the cellular and molecular mechanisms are unknown. In this study, SB was found to enhance the catalytic activity of 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2), a rate-limiting enzyme in ketogenesis, to promote ketone body production in hepatocytes. SB administrated by gavage or intraperitoneal injection significantly induced blood β-hydroxybutyrate (BHB) in mice. BHB production was induced in the primary hepatocytes by SB. Protein succinylation was altered by SB in the liver tissues with down-regulation in 58 proteins and up-regulation in 26 proteins in the proteomics analysis. However, the alteration was mostly observed in mitochondrial proteins with 41% down- and 65% up-regulation, respectively. Succinylation status of HMGCS2 protein was altered by a reduction at two sites (K221 and K358) without a change in the protein level. The SB effect was significantly reduced by a SIRT5 inhibitor and in Sirt5-KO mice. The data suggests that SB activated HMGCS2 through SIRT5-mediated desuccinylation for ketone body production by the liver. The effect was not associated with an elevation in NAD⁺/NADH ratio according to our metabolomics analysis. The data provide a novel molecular mechanism for SB activity in the induction of ketone body production.

Keywords

sodium butyrate / succinylation / HMGCS2 / ketogenesis / SIRT5

References

[1] Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers 2020; 6(1): 40

[2] Veech RL, Bradshaw PC, Clarke K, Curtis W, Pawlosky R, King MT. Ketone bodies mimic the life span extending properties of caloric restriction. IUBMB Life 2017; 69(5): 305–314

[3] Sedej S. Ketone bodies to the rescue for an aging heart?. Cardiovasc Res 2018; 114(1): e1–e2

[4] Hernandez AR, Hernandez CM, Campos KT, Truckenbrod LM, Sakarya Y, McQuail Ph DJ, Carter CS, Bizon JL, Maurer AP, Burke SN. The anti-epileptic ketogenic diet alters hippocampal transporter levels and reduces adiposity in aged rats. J Gerontol A Biol Sci Med Sci 2018; 73(4): 450–458

[5] Shippy DC, Wilhelm C, Viharkumar PA, Raife TJ, Ulland TK. β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology. J Neuroinflammation 2020; 17(1): 280

[6] Harvey CJDC, Schofield GM, Williden M. The use of nutritional supplements to induce ketosis and reduce symptoms associated with keto-induction: a narrative review. PeerJ 2018; 6: e4488

[7] Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009; 58(7): 1509–1517

[8] Mollica MP, Mattace Raso G, Cavaliere G, Trinchese G, De Filippo C, Aceto S, Prisco M, Pirozzi C, Di Guida F, Lama A, Crispino M, Tronino D, Di Vaio P, Berni Canani R, Calignano A, Meli R. Butyrate regulates liver mitochondrial function, efficiency, and dynamics in insulin-resistant obese mice. Diabetes 2017; 66(5): 1405–1418

[9] Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 2019; 10: 277

[10] McNabney SM, Henagan TM. Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer, obesity and insulin resistance. Nutrients 2017; 9(12): 1348

[11] Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis?. Neurochem Int 2016; 99: 110–132

[12] Vicente F, Rodríguez ML, Martínez-Fernández A, Soldado A, Argamentería A, Peláez M, de la Roza-Delgado B. Subclinical ketosis on dairy cows in transition period in farms with contrasting butyric acid contents in silages. ScientificWorldJournal 2014; 2014: 279614

[13] Herrick KJ, Hippen AR, Kalscheur KF, Schingoethe DJ, Casper DP, Moreland SC, van Eys JE. Single-dose infusion of sodium butyrate, but not lactose, increases plasma β-hydroxybutyrate and insulin in lactating dairy cows. J Dairy Sci 2017; 100(1): 757–768

[14] Xu Y, Peng S, Cao X, Qian S, Shen S, Luo J, Zhang X, Sun H, Shen WL, Jia W, Ye J. High doses of butyrate induce a reversible body temperature drop through transient proton leak in mitochondria of brain neurons. Life Sci 2021; 278: 119614

[15] Zhang Y, Sun Z, Jia J, Du T, Zhang N, Tang Y, Fang Y, Fang D. Overview of histone modification. Adv Exp Med Biol 2021; 1283: 1–16

[16] Liu H, Wang J, He T, Becker S, Zhang G, Li D, Ma X. Butyrate: a double-edged sword for health?. Adv Nutr 2018; 9(1): 21–29

[17] Kulkarni SS, Cantó C. Mitochondrial post-translational modifications and metabolic control: sirtuins and beyond. Curr Diabetes Rev 2017; 13(4): 338–351

[18] Stram AR, Payne RM. Post-translational modifications in mitochondria: protein signaling in the powerhouse. Cell Mol Life Sci 2016; 73(21): 4063–4073

[19] Cao X, Ye X, Zhang S, Wang L, Xu Y, Peng S, Zhou Y, Peng Y, Li J, Zhang X, Han X, Huang WY, Jia W, Ye J. ADP induces blood glucose through direct and indirect mechanisms in promotion of hepatic gluconeogenesis by elevation of NADH. Front Endocrinol (Lausanne) 2021; 12: 663530

[20] Nanchen A, Fuhrer T, Sauer U. Determination of metabolic flux ratios from ¹³C-experiments and gas chromatography-mass spectrometry data: protocol and principles. Methods Mol Biol 2007; 358: 177–197

[21] Rardin MJ, He W, Nishida Y, Newman JC, Carrico C, Danielson SR, Guo A, Gut P, Sahu AK, Li B, Uppala R, Fitch M, Riiff T, Zhu L, Zhou J, Mulhern D, Stevens RD, Ilkayeva OR, Newgard CB, Jacobson MP, Hellerstein M, Goetzman ES, Gibson BW, Verdin E. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab 2013; 18(6): 920–933

[22] Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang H, Kim J, Woo J, Kim JH, Choi BH, He B, Chen W, Zhang S, Cerione RA, Auwerx J, Hao Q, Lin H. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011; 334(6057): 806–809

[23] Hofer A, Wenz T. Post-translational modification of mitochondria as a novel mode of regulation. Exp Gerontol 2014; 56: 202–220

[24] Henning SJ, Hird FJ. Ketogenesis from butyrate and acetate by the caecum and the colon of rabbits. Biochem J 1972; 130(3): 785–790

[25] Sabari BR, Zhang D, Allis CD, Zhao Y. Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol 2017; 18(2): 90–101

[26] Park J, Chen Y, Tishkoff DX, Peng C, Tan M, Dai L, Xie Z, Zhang Y, Zwaans BM, Skinner ME, Lombard DB, Zhao Y. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell 2013; 50(6): 919–930

[27] Carafa V, Rotili D, Forgione M, Cuomo F, Serretiello E, Hailu GS, Jarho E, Lahtela-Kakkonen M, Mai A, Altucci L. Sirtuin functions and modulation: from chemistry to the clinic. Clin Epigenetics 2016; 8(1): 61

[28] Wang Y, Guo YR, Liu K, Yin Z, Liu R, Xia Y, Tan L, Yang P, Lee JH, Li XJ, Hawke D, Zheng Y, Qian X, Lyu J, He J, Xing D, Tao YJ, Lu Z. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase. Nature 2017; 552(7684): 273–277

[29] Kurmi K, Hitosugi S, Wiese EK, Boakye-Agyeman F, Gonsalves WI, Lou Z, Karnitz LM, Goetz MP, Hitosugi T. Carnitine palmitoyltransferase 1A has a lysine succinyltransferase activity. Cell Rep 2018; 22(6): 1365–1373

[30] Shimazu T, Hirschey MD, Hua L, Dittenhafer-Reed KE, Schwer B, Lombard DB, Li Y, Bunkenborg J, Alt FW, Denu JM, Jacobson MP, Verdin E. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab 2010; 12(6): 654–661

RIGHTS & PERMISSIONS

Higher Education Press